000			02110nam a22004695i 4500
001			978-1-4614-0650-1
003			DE-He213
005			20140220083733.0
007			cr nn 008mamaa
008			110910s2011 xxu| s |||| 0|eng d
020			_a9781461406501 _9978-1-4614-0650-1
024	7		_a10.1007/978-1-4614-0650-1 _2doi
050		4	_aQH506
072		7	_aMBGR _2bicssc
072		7	_aPSD _2bicssc
072		7	_aSCI049000 _2bisacsh
072		7	_aMED067000 _2bisacsh
082	0	4	_a611.01816 _223
100	1		_aCowart, L. Ashley. _eeditor.
245	1	0	_aSphingolipids and Metabolic Disease _h[electronic resource] / _cedited by L. Ashley Cowart.
264		1	_aNew York, NY : _bSpringer New York, _c2011.
300			_aXVIII, 148p. 26 illus. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
490	1		_aAdvances in Experimental Medicine and Biology, _x0065-2598 ; _v721
505	0		_aSphingolipid Metabolism and Analysis in Metabolic Disease -- Sphingolipids and Cardiovascular Diseases: Lipoprotein Metabolism, Atherosclerosis and Cardiomyopathy -- Heart Sphingolipids in Health and Disease -- Blood Sphingolipids in Homeostasis and Pathobiology -- Adipose Tissue and Ceramide Biosynthesis in the Pathogenesis of Obesity -- Sphingolipids and Hepatic Steatosis -- Glycosphingolipids and Insulin Resistance -- Glyco Sphingolipids and Kidney Disease -- Sphingolipid Synthetic Pathways are Major Regulators of Lipid Homeostasis.
520			_aNo back cover text.
650		0	_aMedicine.
650		0	_aMetabolic diseases.
650	1	4	_aBiomedicine.
650	2	4	_aMolecular Medicine.
650	2	4	_aMetabolic Diseases.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9781461406495
830		0	_aAdvances in Experimental Medicine and Biology, _x0065-2598 ; _v721
856	4	0	_uhttp://dx.doi.org/10.1007/978-1-4614-0650-1
912			_aZDB-2-SBL
999			_c106263 _d106263